JPS6119605B2 - - Google Patents
Info
- Publication number
- JPS6119605B2 JPS6119605B2 JP50015230A JP1523075A JPS6119605B2 JP S6119605 B2 JPS6119605 B2 JP S6119605B2 JP 50015230 A JP50015230 A JP 50015230A JP 1523075 A JP1523075 A JP 1523075A JP S6119605 B2 JPS6119605 B2 JP S6119605B2
- Authority
- JP
- Japan
- Prior art keywords
- salt
- solution
- sodium
- cephem
- ylthiomethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US444622A US3928592A (en) | 1974-02-22 | 1974-02-22 | Antibiotic pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS50126817A JPS50126817A (en, 2012) | 1975-10-06 |
| JPS6119605B2 true JPS6119605B2 (en, 2012) | 1986-05-17 |
Family
ID=23765656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50015230A Expired JPS6119605B2 (en, 2012) | 1974-02-22 | 1975-02-05 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US3928592A (en, 2012) |
| JP (1) | JPS6119605B2 (en, 2012) |
| AR (1) | AR203895A1 (en, 2012) |
| AT (1) | AT356264B (en, 2012) |
| BE (1) | BE825653A (en, 2012) |
| CA (1) | CA1043261A (en, 2012) |
| CH (1) | CH620929A5 (en, 2012) |
| CS (1) | CS189689B2 (en, 2012) |
| DD (1) | DD117807A5 (en, 2012) |
| DE (1) | DE2506622C2 (en, 2012) |
| DK (1) | DK153919C (en, 2012) |
| ES (1) | ES434976A1 (en, 2012) |
| FR (1) | FR2261772B1 (en, 2012) |
| GB (1) | GB1493676A (en, 2012) |
| HU (1) | HU174129B (en, 2012) |
| IE (1) | IE40671B1 (en, 2012) |
| IL (1) | IL46650A (en, 2012) |
| NL (1) | NL179976C (en, 2012) |
| PH (1) | PH12058A (en, 2012) |
| PL (1) | PL109311B1 (en, 2012) |
| SE (1) | SE406153B (en, 2012) |
| SU (1) | SU659094A3 (en, 2012) |
| YU (1) | YU41875A (en, 2012) |
| ZA (1) | ZA75975B (en, 2012) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4054738A (en) * | 1975-12-22 | 1977-10-18 | Eli Lilly And Company | Sodium cefamandole crystalline forms |
| JPS5283956A (en) * | 1976-01-01 | 1977-07-13 | Lilly Co Eli | Antibiotic method and medical composition |
| JPS5329936A (en) * | 1976-08-31 | 1978-03-20 | Takeda Chem Ind Ltd | Antibiotic composition |
| JPS5711909A (en) * | 1980-06-23 | 1982-01-21 | Shionogi & Co Ltd | Stable freeze-dried preparation of beta-lactam |
| IL93618A0 (en) * | 1989-03-06 | 1990-12-23 | Lilly Co Eli | Improved diluent formulation for daptomycin |
| JP4873207B2 (ja) * | 2001-02-26 | 2012-02-08 | 東レ・ファインケミカル株式会社 | 光学活性カルボン酸クロリドの精製方法 |
| CN100554271C (zh) * | 2007-07-27 | 2009-10-28 | 苏州中联化学制药有限公司 | 抗菌素头孢孟多酯钠的合成方法 |
| CN101880290B (zh) * | 2010-06-28 | 2012-03-07 | 海南新中正制药有限公司 | 头孢孟多酯钠的制备方法 |
| WO2013057196A1 (en) * | 2011-10-20 | 2013-04-25 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Process for the preparation of cefamandole nafate |
| WO2013057197A1 (en) * | 2011-10-20 | 2013-04-25 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Process for the formylation of cefamandole |
| US9834567B1 (en) * | 2014-12-16 | 2017-12-05 | Tianjin University | Crystalline form of cefamandole nafate compound, preparation and preparing method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1767891C3 (de) * | 1968-06-28 | 1980-10-30 | Pfizer | Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat |
| US3641021A (en) * | 1969-04-18 | 1972-02-08 | Lilly Co Eli | 3 7-(ring-substituted) cephalosporin compounds |
-
1974
- 1974-02-22 US US444622A patent/US3928592A/en not_active Expired - Lifetime
-
1975
- 1975-02-05 JP JP50015230A patent/JPS6119605B2/ja not_active Expired
- 1975-02-17 ZA ZA00750975A patent/ZA75975B/xx unknown
- 1975-02-17 DE DE2506622A patent/DE2506622C2/de not_active Expired
- 1975-02-18 IL IL46650A patent/IL46650A/en unknown
- 1975-02-18 BE BE1006466A patent/BE825653A/xx not_active IP Right Cessation
- 1975-02-18 FR FR7505039A patent/FR2261772B1/fr not_active Expired
- 1975-02-19 AR AR257697A patent/AR203895A1/es active
- 1975-02-20 DD DD184320A patent/DD117807A5/xx unknown
- 1975-02-20 AT AT128475A patent/AT356264B/de not_active IP Right Cessation
- 1975-02-20 PL PL1975178215A patent/PL109311B1/pl unknown
- 1975-02-20 NL NLAANVRAGE7502045,A patent/NL179976C/xx not_active IP Right Cessation
- 1975-02-20 GB GB7111/75A patent/GB1493676A/en not_active Expired
- 1975-02-21 IE IE356/75A patent/IE40671B1/xx unknown
- 1975-02-21 CS CS751158A patent/CS189689B2/cs unknown
- 1975-02-21 YU YU00418/75A patent/YU41875A/xx unknown
- 1975-02-21 DK DK065575A patent/DK153919C/da not_active IP Right Cessation
- 1975-02-21 PH PH16830A patent/PH12058A/en unknown
- 1975-02-21 ES ES434976A patent/ES434976A1/es not_active Expired
- 1975-02-21 HU HU75EI599A patent/HU174129B/hu unknown
- 1975-02-21 SE SE7501985A patent/SE406153B/xx not_active IP Right Cessation
- 1975-02-21 SU SU752109902A patent/SU659094A3/ru active
- 1975-02-21 CA CA220,537A patent/CA1043261A/en not_active Expired
- 1975-02-21 CH CH216575A patent/CH620929A5/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU663471B2 (en) | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions | |
| KR0180798B1 (ko) | 결정성 페니실린 유도체, 그의 제법 및 용도 | |
| JPH08507519A (ja) | 結晶性セフチオフル遊離酸 | |
| JPS6119605B2 (en, 2012) | ||
| US8853389B2 (en) | Process for refining cefmetazole sodium | |
| US4470980A (en) | Method of increasing oral absorption of β-lactam antibiotics | |
| JPH10511967A (ja) | エンロフロキサシンの注射用もしくは注入用溶液 | |
| EP0329286B1 (en) | Zinc ceftiofur complexes | |
| JPS5925377A (ja) | メトロニダゾ−ルとｎ，ｎ−ジメチルグリシンとのエステルおよびその酸付加湿 | |
| JP2703964B2 (ja) | セファロスポリン抗生物質類 | |
| AU2010295269B2 (en) | Compositions and methods for treating bacterial infections using ceftaroline | |
| US11124526B2 (en) | Crystalline beta-lactamase inhibitor | |
| KR930007263B1 (ko) | 세프-3-엠-4-카르복실산 유도체의 제조방법 | |
| KR800000604B1 (ko) | 비경구용 0-포밀세파만돌 나트륨염제제의 제조방법 | |
| CN116284051B (zh) | 一种头孢地尼烷酸衍生物及其制备方法和应用 | |
| JP2761005B2 (ja) | セファロスポリン含有注射用組成物 | |
| JPS6254313B2 (en, 2012) | ||
| KR101142582B1 (ko) | β-락타마제 효소에 저항성을 갖는 세팔로스포린 에스테르화합물 및 이의 염 | |
| US4035381A (en) | Antibacterial agents | |
| JPS63154622A (ja) | セフアロスポリン誘導体を有効成分とする哺乳動物用抗菌剤 | |
| JP3012986B2 (ja) | セフェム化合物及びその製造法 | |
| JPH0692970A (ja) | トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法 | |
| SU1140688A3 (ru) | Способ получени низших алканоилоксиалкиловых сложных диэфиров производного цефалоспорина | |
| US4001409A (en) | Injectable formulations of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid | |
| JPH0315632B2 (en, 2012) |